A patient is administered gentamicin and complains of sudden hearing loss. What
should the nurse practitioner - ANS-Contact MD/Discontinue medication
... [Show More] (symptom of
ototoxicity)
A patient is taking a fluoroquinolone; what are the most serious adverse effects? P. 721
- ANS-Tendonitis and tendon rupture , C. diff infection, Hypersensitivity reactions,
Stevens-Johnsons Syndrome (Rash eyes, nose, mouth, genitals- skin dies and heals
after rash)
According to the American College of Cardiology and the American Heart Association,
what are the guidelines related to prophylactic antibiotics prior to a dental appointment?
P. 700 - ANS-Prophylaxis against infective endocarditis is reasonable for the following
patients at highest risk for adverse outcomes from infective endocarditis who of either
gingival tissue or the periapical region of teeth or perforation of the oral mucosa:
Patients with prosthetic cardiac valves or prosthetic material used for cardiac valve
repair. Patients with previous infective endocarditis. Patients with congenital heart
defect (CHD). Unrepaired cyanotic CHD, including palliative shunts and conduits.
Completely repaired congenital heart defect repaired with prosthetic material or device,
whether placed by surgery or by catheter intervention, during the first 6 months after the
procedure. Repaired CHD with residual defects at the site or adjacent to the site of a
prosthetic patch or prosthetic device (both of which inhibit endothelialization). Cardiac
transplant recipients with valve regurgitation due to a structurally abnormal valve.
Carbopenems (PsA, broad spectrum) - ANS-Imipenem, Doripenem (increased risk of
death in VAP), Meropenem, Ertapenem (no PsA coverage)
Differentiate between oral and parenteral vancomycin. P. 758-759 - ANS-Parenteral:
bactericidal for GP organisms, MRSA, monitor renal function. systemic therapy. Oral:
pseudomembranous colitis, or c-diff, not absorbed, (metronidazole DOC), local therapy
Fifth generation Cephalosporins - ANS-Treats MRSA (IV) ceftaroline
First generation Cephalosporins - ANS-Effective against Gram + (PO) cephalexin,
cefadroxil (IV) cefazolin [Show Less]